ASHP

Pharmacists are experiencing abuse too -- but they're not always sure how to respond

Training for Tennessee police officers yielded small gains in overdose response outlooks

Regional clinical pharmacists helped community oncology practices navigate logistics, financials

A daily audit of EHR and dispensing machines revealed documentation mistakes, other errors

Major gaps in methodology revealed in studies evaluating posture and pharmacokinetics

Medication safety group previews new best practices for next year

Program reports growth and better outcomes

Introduction of biosimilars falling behind that of other countries

This practice "jeopardizes patient care," says ASHP official

Small, rural sites may be uniquely affected by Joint Commission standards expected in 2022

Clinicians are not always following the guidelines

LAS VEGAS -- Among the many factors that contribute to the burgeoning costs associated with Clostridium difficile infections are long hospital stays, particularly in intensive care units, and the need for multiple specialist consultations, a chart review determined.

LAS VEGAS -- The oral BRAF inhibitor vemurafenib (Zelboraf) increased survival in patients with metastatic melanoma, but the cost may not justify its use in a state Medicaid program, an analysis suggested.

LAS VEGAS -- Riluzole (Rilutek) should remain on the Veterans Administration formulary as a treatment for patients with amyotrophic lateral sclerosis, despite having only modest benefits and considerable cost, a researcher said here.